Biotechnology News

February 4, 2013

RAYNHAM, Mass.--(BUSINESS WIRE)--Medrobotics Corp., announced the appointment of Richard S. Walsh as Vice-President Global Sales today. The appointment coincides with Medrobotics’ anticipated commercial launches in Europe and U.S.

February 4, 2013

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--CRF Health becomes the first eCOA company to complete a full validation study for Professor Juniper’s ACQ and AQLQ questionnaires to the “Gold Standard".

February 4, 2013

AUBURNDALE, Mass.--(BUSINESS WIRE)--Vascular Nanotransfer Technologies (“VNT”) (www.vnanotech.com), an emerging medical technology company that has developed an innovative platform...

February 4, 2013

RALEIGH, N.C., & TILBURG, the Netherlands--(BUSINESS WIRE)--HealthLink Europe expands footprint in Europe for U.S.-based medtech companies, vertically integrating key operations and services

February 4, 2013

SEATTLE--(BUSINESS WIRE)--Natural Molecular Testing Corp. has announced its new Medical Advisory Board to support the company's advances and initiatives in medical genomics and personalized medicine.

February 4, 2013

PARSIPPANY, N.J.--(BUSINESS WIRE)--Medical Device Using Evonik’s VESTAKEEP® PEEK Receives First FDA Spinal 510(K) Approval.
K7C™ Cervical Spacer Gains Intervertebral Body Fusion Clearance

February 4, 2013

WINNIPEG, Manitoba--(BUSINESS WIRE)--The Life Science Association of Manitoba (LSAM) presents its annual Life Science Awards as a way to recognize the leaders and innovators of the life science community.

February 4, 2013

MADISON, Wis.--(BUSINESS WIRE)--On Wednesday, February 13th Ian Hunt, head of Protein Sciences for the Center of Proteomic Chemistry at the Novartis Institutes for Biomedical Research (NIBR) campus in Cambridge, MA, will be...

February 4, 2013

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Pharmaceuticals (NYSE MKT: NAVB) to Collaborate with Maimonides Medical Center on Clinical Trial Utilizing Lymphoseek® for Lymphatic Mapping in Colorectal Cancer

February 4, 2013

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, February 14, 2013, at 4:00 p.m. EST to discuss the Company’s financial and...

February 4, 2013

BISHOPS STORTFORD, United Kingdom--(BUSINESS WIRE)--Dotmatics has released Bioregister, a biological registration system designed in collaboration with pharma and biotech organisations, the company announced today.

February 4, 2013

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the first patient began treatment in the...

February 4, 2013

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc. announces the acquisition of all GVAX assets from BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), including intellectual property and cell lines. This acquisition substantially expands Aduro’s...

February 4, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and 2012 full year financial results on February 12, 2013, after close of market.

February 4, 2013

CHICAGO--(BUSINESS WIRE)--Novian Health, developer of Novilase® Breast Therapy, announced today that it has successfully completed a funding round totaling $11 million.

February 4, 2013

SAN ANTONIO--(BUSINESS WIRE)--Graftjacket® Regenerative Tissue Matrix Receives Medicare Reimbursement in Ten Northwestern States; Approximately 3.7 Million People Gain Access to Effective Treatment Option for Diabetic Foot Ulcers

February 4, 2013

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled...

February 4, 2013

WATERTOWN, Mass.--(BUSINESS WIRE)--Blend announced that its scientific co-founder, Robert S. Langer, ScD, received the National Medal of Technology and Innovation at the White House from President Barack Obama at a ceremony 2/1/13.

February 4, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences (Nasdaq:GILD) today announced topline results from two Phase 3 studies, FISSION and NEUTRINO, evaluating a 12-week course of the once-daily nucleotide sofosbuvir in combination with ribavirin...

February 4, 2013

CINCINNATI--(BUSINESS WIRE)--Ethicon announces the FDA 510(k) clearance for the ENSEAL® G2 Articulating Tissue Sealer - the first articulating advanced energy device on the market.

February 4, 2013

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, announced that President and Chief Executive Officer Steven A. Kriegsman and Vice President of Business...

February 4, 2013

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) plans to present at three upcoming investor conferences. The conferences will be webcast live and will be available in the Investor Relations section of the Company’s Web site at...

February 4, 2013

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the first quarter ended December 31, 2012 at approximately 8:30 a.m. EST on Thursday, February 14, 2013. BASi has scheduled a...

February 4, 2013

SAN JOSE, Calif.--(BUSINESS WIRE)--The Thermo Scientific Dionex GlycanPac AXH-1 HPLC column is designed to enable simultaneous separation of biologically-important glycans based on charge, size and polarity.

February 4, 2013

HONOLULU--(BUSINESS WIRE)--The Penumbra DDC family can be used to deliver a broad array of neuro-endovascular therapies.

February 4, 2013

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announces the first patient implant of its 25 mm Portico Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial.

February 4, 2013

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--The MammaPrint breast cancer test can dramatically reduce the number of women who need to undergo chemotherapy to treat the disease, according to a newly published study.

February 4, 2013

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Dr. Geert Cauwenbergh, will present at the 15th Annual BIO CEO & Investor Conference on Monday, February 11th at 4:00pm ET. Dr. Cauwenbergh will discuss the development of RXI-109.

February 4, 2013

JERUSALEM--(BUSINESS WIRE)--Yissum, the Research and Development Company of the Hebrew University at Jerusalem introduces new chickpea varieties, which retain high nutritional values yet exhibit improved synchronization between flowering and the...

February 4, 2013

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX)(TASE: BLRX), a biopharmaceutical development company, notes that, as previously disclosed, results from the interim analysis of the Phase II/III CLARITY clinical trial of BL-1020, a first...

February 4, 2013

RICHMOND Va. & LONDON & SYDNEY--(BUSINESS WIRE)--AmpliPhi today announced that the US Patent and Trademark Office has issued a Notice of Allowance for U.S. Patent Application No. 13/333,684 entitled “Bacteriophage-Containing Therapeutic...

February 4, 2013

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC: NNVC) raised $6M from four equity investors. The Company reports having approximately $19M of cash in hand with this raise.

February 4, 2013

LONDON--(BUSINESS WIRE)--Data were published in The Lancet today from a Phase IIb clinical trial evaluating the safety and efficacy of MVA85A in preventing tuberculosis (TB) in infants. MVA85A is a TB vaccine candidate designed to boost immune...

February 4, 2013

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Announces Japanese Government Funding for Unoprostone Isopropyl Development in Retinitis Pigmentosa

February 4, 2013

JERUSALEM--(BUSINESS WIRE)--Gamida Cell announced today that its flagship product, StemEx, reached its primary endpoint of improving overall survival in a Phase II/III study which compared the use of StemEx as part of a transplantation regimen to...

February 4, 2013

PARSIPPANY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Medicines Company (Nasdaq: MDCO) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that they have formed an exclusive global...

February 4, 2013

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--MindChild Medical, Inc. will present the MERIDIAN™ non-invasive fetal heart monitor at the 33rd Annual Meeting for the Society for Maternal Fetal Medicine (SMFM) to be Held February 13-15, 2013 at the Hilton...

February 4, 2013

CHALFONT ST. GILES, UK--(BUSINESS WIRE)--GE is committed to the fight against cancer, the leading cause of death worldwide. GE has made numerous investment and innovations over the past year and supports World Cancer Day.

February 4, 2013

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Karolinska Development AB (publ) (STO:KDEV) has entered into an agreement with Mayo Clinic with the aim of identifying commercialization opportunities in Mayo’s life science innovations that will...

February 4, 2013

HYDERABAD, India--(BUSINESS WIRE)--US FDA extends license of the GVK BIO Biomarker database.

February 1, 2013

VALENCIA, Calif.--(BUSINESS WIRE)--Recipients in the US, Canada and Europe who choose Advanced Bionics now will have the option to select the next-generation sound processor and hear with the latest technology when it is available.

February 1, 2013

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that Health Canada has issued a Notice of Compliance with conditions (NOC/c), authorizing marketing of ADCETRIS for two lymphoma indications: (1) the treatment...

February 1, 2013

WASHINGTON--(BUSINESS WIRE)--BIO announces plenary sessions, Business Roundtables and Therapeutic Workshops selected for the 15th annual BIO CEO & Investor Conference, to be held in New York City, February 11 - 12, 2013.

February 1, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Republic of Ireland Approves Funding for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People with a Specific Genetic Mutation (G551D)

February 1, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Living Proof Congratulates Co-Found Robert Langer on Receiving the National Medal of Technology and Innovation Today at a White House Ceremony

February 1, 2013

FARMINGTON, Conn.--(BUSINESS WIRE)--At DJO Surgical, our end goal is to help patients reach their greatest potential. We strive to achieve this through innovation, proven results, and clinical heritage.

February 1, 2013

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its former animal health business unit, now a standalone company named ZoetisTM, began trading on the New York Stock Exchange under the ticker symbol “ZTS.” “This is a proud...